J. Vollmer

发表

Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists.

A. Krieg, J. Vollmer, 2009, Advanced drug delivery reviews.

Identification of RNA Sequence Motifs Stimulating Sequence-Specific TLR8-Dependent Immune Responses1

Marion Jurk, G. Mutwiri, A. Vicari, 2008, The Journal of Immunology.

Toll‐like receptor (TLR) 3 immune modulation by unformulated small interfering RNA or DNA and the role of CD14 (in TLR‐mediated effects)

J. Vollmer, C. Montino, A. Forsbach, 2012, Immunology.

Sequences derived from self-RNA containing certain natural modifications act as suppressors of RNA-mediated inflammatory immune responses.

Marion Jurk, A. Krieg, J. Vollmer, 2009, International immunology.

Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities

P. Payette, Marion Jurk, A. Krieg, 2004, European journal of immunology.

Guanine-Modified Inhibitory Oligonucleotides Efficiently Impair TLR7- and TLR9-Mediated Immune Responses of Human Immune Cells

H. Wagner, T. Miethke, Marion Jurk, 2015, PloS one.

Guanine Modification of Inhibitory Oligonucleotides Potentiates Their Suppressive Function

H. Wagner, T. Miethke, Marion Jurk, 2013, The Journal of Immunology.

Dual or triple activation of TLR7, TLR8, and/or TLR9 by single-stranded oligoribonucleotides.

C. Schmitz, J. Vollmer, A. Forsbach, 2011, Nucleic acid therapeutics.

Autophagy links pattern recognition receptors to tumor cell apoptosis.

J. Vollmer, 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

Characterization of conserved viral leader RNA sequences that stimulate innate immunity through TLRs.

G. Lipford, J. Vollmer, C. Montino, 2007, Oligonucleotides.

Modulating responsiveness of human TLR7 and 8 to small molecule ligands with T‐rich phosphorothiate oligodeoxynucleotides

Marion Jurk, A. Krieg, J. Vollmer, 2006, European journal of immunology.

Cross‐reactive trinitrophenylated peptides as antigens for class II major histocompatibility complex‐restricted T cells and inducers of contact sensitivity in mice. Limited T cell receptor repertoire

J. Vollmer, H. Weltzien, U. Pflugfelder, 1995, European journal of immunology.

Immunostimulatory effects of three classes of CpG oligodeoxynucleotides on PBMC from HCV chronic carriers

A. Krieg, H. Davis, J. Vollmer, 2008, Journal of immune based therapies and vaccines.

CpG oligodeoxynucleotides stimulate IFN-γ-inducible protein-10 production in human B cells

Marion Jurk, A. Krieg, G. Lipford, 2004 .

Functional expression and analysis of a human HLA-DQ restricted, nickel-reactive T cell receptor in mouse hybridoma cells.

J. Vollmer, H. Weltzien, C. Moulon, 1999, The Journal of investigative dermatology.

Components of the Ligand for a Ni++ Reactive Human T Cell Clone

J. Kappler, P. Marrack, J. Vollmer, 2003, The Journal of experimental medicine.

Therapeutic Applications of Synthetic CpG Oligodeoxynucleotides as TLR9 Agonists for Immune Modulation

Marion Jurk, J. Vollmer, M. Jurk, 2012, BioDrugs.

This information is current as Excludes Superantigen-Like Recognition Complementarity-Determining Region 3 but Indicates Contacts with TCR Reactivity in Human Nickel Allergy

J. Vollmer, H. Weltzien, C. Moulon, 2013 .

Compositions de ligands tlr et d'antiviraux

Robert L. Bratzler, A. Vicari, J. Vollmer, 2007 .

Positive T cell co-stimulation by TLR7/8 ligands is dependent on the cellular environment.

Marion Jurk, A. Krieg, J. Vollmer, 2011, Immunobiology.

C-Class CpG ODN: sequence requirements and characterization of immunostimulatory activities on mRNA level.

Marion Jurk, A. Krieg, J. Vollmer, 2004, Immunobiology.

Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll‐like receptor 9 dependent T helper type 2 biased immune stimulation

P. Payette, Marion Jurk, A. Krieg, 2004, Immunology.

The TLR7/8 ligand resiquimod targets monocyte-derived dendritic cell differentiation via TLR8 and augments functional dendritic cell generation.

H. Hackstein, G. Bein, Marion Jurk, 2011, Cellular immunology.

Highly immunostimulatory CpG-free oligodeoxynucleotides for activation of human leukocytes.

A. Krieg, J. Vollmer, Z. Ballas, 2002, Antisense & nucleic acid drug development.

Impact of delivery systems on siRNA immune activation and RNA interference.

Marion Jurk, J. Vollmer, C. Montino, 2012, Immunology letters.

TLR 8-Dependent Immune Responses Stimulating Sequence-Specific Identification of RNA Sequence Motifs

Marion Jurk, G. Mutwiri, A. Vicari, 2008 .

Antigen contacts by Ni-reactive TCR: typical αβ chain cooperation versus α chain-dominated specificity

J. Vollmer, H. Weltzien, K. Gamerdinger, 2000 .

Immunopharmacology of CpG Oligodeoxynucleotides and Ribavirin

Marion Jurk, A. Krieg, J. Vollmer, 2004, Antimicrobial Agents and Chemotherapy.

A novel class of immune-stimulatory CpG oligodeoxynucleotides unifies high potency in type I interferon induction with preferred structural properties.

A. Krieg, J. Vollmer, U. Samulowitz, 2010, Oligonucleotides.

Differential effects of P-class versus other CpG oligodeoxynucleotide classes on the impaired innate immunity of plasmacytoid dendritic cells in HIV type 1 infection.

B. Schmidt, K. Korn, M. Helm, 2010, AIDS research and human retroviruses.

TCR reactivity in human nickel allergy indicates contacts with complementarity-determining region 3 but excludes superantigen-like recognition.

J. Vollmer, H. Weltzien, C. Moulon, 1999, Journal of immunology.

Dominance of the BV17 element in nickel‐specific human T cell receptors relates to severity of contact sensitivity

J. Vollmer, H. Weltzien, Michael Fritz, 1997, European journal of immunology.

Characterization of processing requirements and metal cross‐reactivities in T cell clones from patients with allergic contact dermatitis to nickel

J. Vollmer, H. Weltzien, C. Moulon, 1995, European journal of immunology.

Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848

H. Wagner, Marion Jurk, A. Krieg, 2002, Nature Immunology.

Arenavirus Induced CCL5 Expression Causes NK Cell-Mediated Melanoma Regression

D. Schadendorf, A. Pandyra, D. Häussinger, 2020, Frontiers in Immunology.

Modulation of CpG oligodeoxynucleotide-mediated immune stimulation by locked nucleic acid (LNA).

Marion Jurk, A. Krieg, J. Vollmer, 2004, Oligonucleotides.

Editorial: CpG Motifs to Modulate Innate and Adaptive Immune Responses

J. Vollmer, 2006, International reviews of immunology.

TLR9 in Health and Disease

J. Vollmer, 2006, International reviews of immunology.

Stimulation of the Immune System by Therapeutic Antisense Oligodeoxynucleotides and Small Interfering RNAs via Nucleic Acid Receptors

J. Vollmer, Denise Richardt-Pargmann, 2009, Annals of the New York Academy of Sciences.

Progress in drug development of immunostimulatory CpG oligodeoxynucleotide ligands for TLR9

J. Vollmer, 2005, Expert opinion on biological therapy.

Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune‐modulatory activity

Marion Jurk, A. Krieg, H. Davis, 2004, Journal of leukocyte biology.

Identification of novel oligonucleotides from mitochondrial DNA that spontaneously induce plasmacytoid dendritic cell activation

B. Schmidt, J. Vollmer, P. Schuster, 2013, Journal of leukocyte biology.

Negative regulation of the type I interferon signaling pathway by synthetic Toll-like receptor 7 ligands.

Toan D. Nguyen, Marion Jurk, J. Vollmer, 2012, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8

S. Akira, C. Schmitz, Marion Jurk, 2005, The Journal of experimental medicine.

Uptake, efficacy, and systemic distribution of naked, inhaled short interfering RNA (siRNA) and locked nucleic acid (LNA) antisense.

M. Yeadon, M. Frick, R. Subramanian, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Chemically Modified Oligonucleotides Modulate an Epigenetically Varied and Transient Form of Transcription Silencing of HIV-1 in Human Cells

Stuart E. Knowling, K. Morris, J. Vollmer, 2012, Molecular therapy. Nucleic acids.

Toll‐like receptors 7, 8, and 9: linking innate immunity to autoimmunity

A. Krieg, J. Vollmer, 2007, Immunological reviews.

Phosphoglycerate kinase 1 as a promoter of metastasis in colon cancer.

H. Northoff, B. Sipos, J. Vollmer, 2013, International journal of oncology.

Induction of tumor stem cell differentiation—novel strategy to overcome therapy resistance in gastric cancer

H. Northoff, F. Fend, J. Vollmer, 2013, Langenbeck's Archives of Surgery.

Toll-like receptors involved in the response to microbial pathogens: development of agonists for toll-like receptor 9.

J. Vollmer, C. Schetter, 2004, Current opinion in drug discovery & development.

Structure–Activity Relationship Studies on the Immune Stimulatory Effects of Base‐Modified CpG Toll‐Like Receptor 9 Agonists

Marion Jurk, A. Krieg, J. Vollmer, 2006, ChemMedChem.

The Use of RNA and CpG DNA as Nucleic Acid‐Based Therapeutics

J. Vollmer, 2010 .

Chronic Immune Activation in HIV-1 Infection Contributes to Reduced Interferon Alpha Production via Enhanced CD40:CD40 Ligand Interaction

B. Schmidt, M. Helm, T. Harrer, 2012, PloS one.

A subset of human plasmacytoid dendritic cells expresses CD8α upon exposure to herpes simplex virus type 1

B. Schmidt, J. Vollmer, P. Schuster, 2015, Front. Microbiol..

Immunostimulatory potential of silencing RNAs can be mediated by a non-uridine-rich toll-like receptor 7 motif.

Marion Jurk, A. Vicari, A. Krieg, 2011, Nucleic acid therapeutics.

Combination therapy including CpG oligodeoxynucleotides and entecavir induces early viral response and enhanced inhibition of viral replication in a woodchuck model of chronic hepadnaviral infection.

Z. Meng, Mengji Lu, E. Zhang, 2016, Antiviral research.

CpG oligodeoxynucleotides stimulate IFN-gamma-inducible protein-10 production in human B cells.

Marion Jurk, A. Krieg, G. Lipford, 2004, Journal of endotoxin research.

In vitro effects of adjuvants on B cells.

J. Vollmer, Hanna Bellert, 2010, Methods in molecular biology.

Components of the Ligand for a Ni++ Reactive Human T Cell Clone

J. Kappler, P. Marrack, J. Vollmer, 2003, The Journal of experimental medicine.